Development of Integrin αVβ3 Agonists to Promote Remyelination in Multiple Sclerosis

Therapeutic Innovation Australia 2026 Open access

Read full text
Authors: Therapeutic Innovation Australia
DOI: 10.82292/2f7w-jp96
Cited by: 0

Fields of Study & Subjects

Multiple Sclerosis Research Studies Cell Adhesion Molecules Research Neuroinflammation and Neurodegeneration Mechanisms

Publication details

Journal / source
Therapeutic Innovation Australia
Publication date
17 February 2026
Language
EN